Enrique A Conterno sold $1.2M of KYNB
Chief Executive Officer at FIBROGEN INC. 56,261 shares at an average of $20.62, traded Mar 8, 2023, filed Mar 10, 2023.
Score components
- +25RoleCEO
- +25Trade size$1.2M at market
- +5Share of holdings soldSold 15% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001209191-23-018064, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 8, 2023 | SOpen-market sale Common Stock | -24,672 | $21.16 | $522k | 356,111 | Mar 10, 2023 |
| Mar 8, 2023 | AGrant or award Common Stock | +23,120 | $0.00 | $0 | 379,231 | Mar 10, 2023 |
| Mar 8, 2023 | AGrant or award Common Stock | +37,229 | $0.00 | $0 | 416,460 | Mar 10, 2023 |
| Mar 10, 2023 | SOpen-market sale Common Stock | -12,103 | $20.20 | $244k | 404,357 | Mar 10, 2023 |
| Mar 10, 2023 | SOpen-market sale Common Stock | -19,486 | $20.20 | $394k | 384,868 | Mar 10, 2023 |
Related signals
Other insiders at FIBROGEN INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $20k 2,800 shares | +11% | |
| 36Weak | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $20k 2,800 shares | +11% | |
| 42Moderate | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $34k 3,700 shares | +17% | |
| 53Moderate | KYNBbuy FIBROGEN INC | James A Schoeneck director | $119k 23,567 shares | +146% | |
| 46Moderate | FIBROGEN INC | Thane Wettig CEO | $51k 145,000 shares | +36% | |
| 43Moderate | FIBROGEN INC | James A Schoeneck director | $105k 300,000 shares | +407% | |
| 34Weak | KYNBbuy FIBROGEN INC | Deyaa Adib Chief Medical Officer | $26k 22,123 shares | +37% | |
| 46Moderate | KYNBbuy FIBROGEN INC | Thane Wettig CEO | $95k 50,000 shares | +12% | |
| 15Weak | KYNBsell FIBROGEN INC | Thane Wettig Chief Commercial Officer | $17k 905 shares | -1% | |
| 45Moderate | FIBROGEN INC | Christine Chung SVP, China Operations | $330k 15,960 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.